PTGX earnings
Protagonist Therapeutics (PTGX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
PTGX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 2.29 | 2.23 | 2.69% | $213.47M |
| Q1 2026 | May 5, 2026 | 0.05 | -0.65 | 107.69% | $56.37M |
| Q4 2025 | Feb 25, 2026 | -0.69 | -0.53 | -30.19% | $7.44M |
| Q3 2025 | Nov 6, 2025 | -0.62 | -0.59 | -5.08% | $4.71M |
| Q2 2025 | Aug 6, 2025 | -0.55 | -0.53 | -3.77% | $5.55M |
| Q1 2025 | May 6, 2025 | -0.19 | -0.50 | 62.00% | $28.32M |
| Q4 2024 | Feb 21, 2025 | 1.98 | 0.06 | 3200.00% | $170.64M |
| Q3 2024 | Nov 7, 2024 | -0.54 | -0.59 | 8.47% | $4.67M |
| Q2 2024 | Aug 6, 2024 | -0.50 | -0.50 | 0.00% | $4.17M |
| Q1 2024 | May 7, 2024 | 3.26 | 1.19 | 173.95% | $254.95M |
| Q4 2023 | Feb 27, 2024 | 0.44 | 0.03 | 1425.13% | $60.00M |
| Q3 2023 | Nov 2, 2023 | -0.58 | -0.68 | 14.71% | – |
| Aug 3, 2023 | -0.68 | -0.65 | -4.62% | – | |
| May 4, 2023 | -0.67 | -0.69 | 2.90% | – | |
| Mar 15, 2023 | -0.69 | -0.67 | -2.99% | – | |
| Nov 8, 2022 | -0.64 | -0.94 | 31.91% | – | |
| Aug 4, 2022 | -0.84 | -0.99 | 15.15% | – | |
| May 4, 2022 | -0.43 | -0.67 | 35.82% | – | |
| Feb 28, 2022 | -0.77 | -0.79 | 2.53% | – | |
| Nov 3, 2021 | -0.70 | -0.67 | -4.48% | – |
- PTGX reports next on Nov 5, 2026, with EPS of 2.49 expected.
- PTGX beat EPS estimates in 23 of its last 41 reports.
Updated 2026-11-03 01:00 UTC